Drug
Bps804 KG
Bps804 KG: highest development phase Phase 2, developed by Ultragenyx Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Ultragenyx Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| BPS804 20mg/Kg NCT01406548 | Phase 2 | Osteopenia |
Latest
No recent events.
Follow Bps804 KG on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.